Percent change in yearly crude rates (between 2019 and 2021 and between 2019 and 2024) by gender and state. by Tony Wong (779773)

Fig 6 - by Kirralise J. Hansford (20670869)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”

Yearly crude rates normalized by their 1999 value. by Tony Wong (779773)

Alpha and beta diversity of gut microbiome. by Xueyan Lin (448667)

IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. by Iratxe Zuazo-Gaztelu (21071939)

Alcohol-related monthly crude rates for ages 15 and older between 2018 and 2024, stratified by gender and race. by Tony Wong (779773)

Cnot4 Het does not affect mRNA expression of metabolic genes as well as serum lipid levels or glucose tolerance. by Tomokazu Yamaguchi (8284989)

Cnot4 haploinsufficiency impairs rosiglitazone-induced transcriptional activity of PPAR by Tomokazu Yamaguchi (8284989)

Effect of down-regulation and up-regulation of CRNN on cell apoptosis. by Changji Li (4806930)

Effect of down-regulation and up-regulation of CRNN on cell proliferation. by Changji Li (4806930)

Endogenous IRE1 protein can localize to the nuclear envelope. by Iratxe Zuazo-Gaztelu (21071939)

The effect of CRNN downregulation on migration and invasion ability in cSCC cells. by Changji Li (4806930)

Crude rates in select US counties between 1999 and 2024. by Tony Wong (779773)

Cnot4 mediates differentiation into adipocytes from mouse embryonic fibroblasts. by Tomokazu Yamaguchi (8284989)

IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. by Iratxe Zuazo-Gaztelu (21071939)